• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.通过聚合酶链反应-限制性片段长度多态性技术对小柳原田病进行HLA-DRB1分型及与DRB1*0405和DRB1*0410的强关联
Br J Ophthalmol. 1994 Mar;78(3):223-6. doi: 10.1136/bjo.78.3.223.
2
Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease.HLA - DRB1*04和 - DQB1*04等位基因与小柳原田病完全相关。
Hum Immunol. 1994 Mar;39(3):169-76. doi: 10.1016/0198-8859(94)90257-7.
3
[The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].[HLA-DR4基因亚型与Vogt-小柳-原田综合征的关联]
Zhonghua Yan Ke Za Zhi. 1997 Jul;33(4):268-71.
4
Clinical and immunogenetic investigation of a Laotian patient with Vogt-Koyanagi-Harada's disease.一名老挝Vogt-小柳-原田病患者的临床与免疫遗传学调查
Ophthalmologica. 1996;210(2):112-4. doi: 10.1159/000310685.
5
Influence of HLA-DRB1 gene variation on the clinical course of Vogt-Koyanagi-Harada disease.HLA-DRB1基因变异对小柳原田病临床病程的影响。
Invest Ophthalmol Vis Sci. 1994 Feb;35(2):752-6.
6
[Association of HLA-DRB genes with Vogt-Koyanagi-Harada syndrome in a Chinese Han population].[中国汉族人群中HLA - DRB基因与Vogt - 小柳 - 原田综合征的关联]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Feb;22(1):36-40.
7
Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease.墨西哥人中HLA II类序列与原田小柳综合征的强关联。
Hum Immunol. 1999 Sep;60(9):875-82. doi: 10.1016/s0198-8859(99)00024-5.
8
A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.DRβ1结构域中一个共享的HLA - DRB1表位与印度患者的Vogt - 小柳 - 原田综合征相关。
Mol Vis. 2010 Mar 5;16:353-8.
9
HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California.南加州患有伏格特-小柳-原田病的混血患者的HLA-DRB1和-DQB1等位基因
Hum Immunol. 2004 Dec;65(12):1477-82. doi: 10.1016/j.humimm.2004.07.236.
10
Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.中国Vogt-小柳-原田(VKH)综合征患者中FCRL3基因多态性研究
Mol Vis. 2009 May 11;15:955-61.

引用本文的文献

1
Unilateral choroidal detachment in an elderly patient with Vogt-Koyanagi-Harada disease: a case report and literature review.老年Vogt-小柳-原田病患者单侧脉络膜脱离:病例报告及文献复习
Front Immunol. 2025 Feb 27;16:1514306. doi: 10.3389/fimmu.2025.1514306. eCollection 2025.
2
Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope-Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice.克拉他汀(一种共享表位拮抗环肽)对小鼠实验性自身免疫性葡萄膜炎的抗炎作用。
Invest Ophthalmol Vis Sci. 2025 Jan 2;66(1):13. doi: 10.1167/iovs.66.1.13.
3
Vogt-Koyanagi-Harada disease-like uveitis induced by nivolumab in metastatic renal cell carcinoma.纳武单抗诱发的转移性肾细胞癌中的Vogt-小柳-原田病样葡萄膜炎
IJU Case Rep. 2024 Oct 21;8(1):36-40. doi: 10.1002/iju5.12801. eCollection 2025 Jan.
4
Vogt-Koyanagi-Harada Disease: A Narrative Review.伏格特-小柳-原田病:一篇叙述性综述
Cureus. 2024 Apr 23;16(4):e58867. doi: 10.7759/cureus.58867. eCollection 2024 Apr.
5
Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review.诊断与管理免疫检查点抑制剂相关葡萄膜炎:综述
Diagnostics (Basel). 2024 Feb 4;14(3):336. doi: 10.3390/diagnostics14030336.
6
Vogt-Koyanagi-Harada Disease and COVID.伏格特-小柳-原田病与新冠病毒
J Clin Med. 2023 Sep 27;12(19):6242. doi: 10.3390/jcm12196242.
7
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients.儿童患者非感染性葡萄膜炎的诊断与治疗。
Paediatr Drugs. 2024 Jan;26(1):31-47. doi: 10.1007/s40272-023-00596-5. Epub 2023 Oct 4.
8
A COVID-19 perspective of Vogt-Koyanagi-Harada disease.Vogt-Koyanagi-Harada 病的 COVID-19 视角。
Indian J Ophthalmol. 2023 Jun;71(6):2587-2591. doi: 10.4103/IJO.IJO_172_23.
9
Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review.伏格特-小柳-原田病:逐步深入了解临床病理学、免疫病理学、诊断及管理的方法:简要综述
J Ophthalmic Inflamm Infect. 2022 May 12;12(1):17. doi: 10.1186/s12348-022-00293-3.
10
High resolution HLA-DRB1 analysis and shared molecular amino acid signature of DRβ1 molecules in Occult hepatitis B infection.隐匿性乙型肝炎感染中高分辨率 HLA-DRB1 分析和 DRβ1 分子的共享分子氨基酸特征。
BMC Immunol. 2022 Apr 25;23(1):22. doi: 10.1186/s12865-022-00496-2.

本文引用的文献

1
MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.人血清细胞毒素的微滴分析法
Nature. 1964 Dec 5;204:998-1000. doi: 10.1038/204998b0.
2
Vogt-Koyanagi-Harada syndrome.伏格特-小柳-原田综合征
Am J Ophthalmol. 1980 Jul;90(1):69-75.
3
Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.白塞病和葡萄膜炎-小柳原田病的免疫学方面
Trans Ophthalmol Soc U K (1962). 1981 Sep;101 (Pt 3)(3):335-41.
4
Genetics and expression of mouse Ia antigens.小鼠Ia抗原的遗传学与表达
Annu Rev Immunol. 1985;3:367-96. doi: 10.1146/annurev.iy.03.040185.002055.
5
Genetic complexity and expression of human class II histocompatibility antigens.人类Ⅱ类组织相容性抗原的遗传复杂性与表达
Immunol Rev. 1985 Jul;85:45-86. doi: 10.1111/j.1600-065x.1985.tb01130.x.
6
Allelic variation in the DR subregion of the human major histocompatibility complex.人类主要组织相容性复合体DR亚区的等位基因变异
Proc Natl Acad Sci U S A. 1987 Sep;84(17):6234-8. doi: 10.1073/pnas.84.17.6234.
7
Progress in understanding HLA and disease associations.人类白细胞抗原(HLA)与疾病关联的认识进展。
Br Med Bull. 1987 Jan;43(1):156-83. doi: 10.1093/oxfordjournals.bmb.a072169.
8
HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.HLA-DQβ基因与胰岛素依赖型糖尿病的易感性和抗性有关。
Nature. 1987;329(6140):599-604. doi: 10.1038/329599a0.
9
Structure of the human class I histocompatibility antigen, HLA-A2.人类I类组织相容性抗原HLA - A2的结构
Nature. 1987;329(6139):506-12. doi: 10.1038/329506a0.
10
Immunogenetics of HLA-associated diseases.
Concepts Immunopathol. 1988;5:80-105.

通过聚合酶链反应-限制性片段长度多态性技术对小柳原田病进行HLA-DRB1分型及与DRB1*0405和DRB1*0410的强关联

HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.

作者信息

Shindo Y, Inoko H, Yamamoto T, Ohno S

机构信息

Department of Ophthalmology, Yokohama City University School of Medicine, Japan.

出版信息

Br J Ophthalmol. 1994 Mar;78(3):223-6. doi: 10.1136/bjo.78.3.223.

DOI:10.1136/bjo.78.3.223
PMID:7908535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC504742/
Abstract

Vogt-Koyanagi-Harada's (VKH) disease is reported to be closely associated with the HLA class II antigen, HLA-DR4. Serologically defined DR4 is further divided into 11 alleles by molecular HLA genotyping. However, no study of HLA-DNA typing of VKH patients has been reported. To clarify molecular genetic mechanism underlying the susceptibility/resistance to VKH disease, HLA-DNA typing of DR antigens (DRB1 genotyping) by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was performed. It was found that DRB10405 showed a significant association with VKH disease compared with the healthy controls (corrected p value < 1 x 10(-5)) and that all the patients had DRB10405 and/or DRB10410. The specific amino acid residue shared only by these two alleles is Ser at position 57 which is located in the antigen binding groove and may influence the immunological function as an antigen-presenting molecule, suggesting that Ser at position 57 plays an important role in the susceptibility to VKH disease, although the possibility that the involvement of the HLA-DQ molecule, DQ4, in strong linkage disequilibrium with DRB10405 and DRB1*0410, cannot be excluded.

摘要

据报道,Vogt-小柳原田病(VKH)与人类白细胞抗原(HLA)II类抗原HLA-DR4密切相关。通过分子HLA基因分型,血清学定义的DR4可进一步分为11个等位基因。然而,尚未有关于VKH患者HLA-DNA分型的研究报道。为了阐明VKH病易感性/抗性的分子遗传机制,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对DR抗原进行HLA-DNA分型(DRB1基因分型)。结果发现,与健康对照相比,DRB10405与VKH病存在显著关联(校正p值<1×10⁻⁵),且所有患者均具有DRB10405和/或DRB10410。这两个等位基因仅共有的特定氨基酸残基是位于抗原结合槽中的第57位丝氨酸,它可能作为抗原呈递分子影响免疫功能,这表明第57位丝氨酸在VKH病易感性中起重要作用,尽管不能排除与DRB10405和DRB1*0410处于强连锁不平衡状态的HLA-DQ分子DQ4的参与可能性。